Drugs / Urinary Follicle-Stimulating Hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02625519 | Dec 2015 → Jan 2019 | — | Instituto Bernabeu | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02310074 Comparator | Jan 2010 → Jun 2014 | hypogonadotropic hypogonadism | Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Urinary follicle-stimulating hormone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02625519 ↗ |
| Known as | uFSH | “Urinary Follicle-Stimulating Hormone (uFSH)” NCT02310074 ↗ |
| Modality | Protein / enzyme biologic | “highly purified urinary follicle-stimulating hormone” NCT02625519 ↗ |